Gerhard Max Gross
8Patents
1h-index
28Co-inventors
51Inventor score
Filing activity: Apr 28, 2000 → Feb 6, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7098214B1 | Dopamine D3 receptor ligands or antagonists for use in the treatment of renal function disorders | Human Necessities | 1 | Expired |
| US11001569B2 | 6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11236084B2 | Substituted azaindoline derivatives as NIK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11186589B2 | Cyanoindoline derivatives as NIK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10905738B2 | Synthetic peptides, prodrugs, pharmaceutical compositions and uses | Human Necessities | 0 | Active |
| US7557105B2 | N-oxides of N-phenyl-2-pyrimidine-amine derivatives | Chemistry; Metallurgy | 0 | Expired |
| US11180487B2 | Substituted cyanoindoline derivatives as NIK inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11136311B2 | Heteroaromatic derivatives as NIK inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.